Strata Skin Sciences Price to Sales Ratio 2010-2023 | SSKN
Historical PS ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The current P/S ratio for Strata Skin Sciences as of May 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Strata Skin Sciences P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-01 | 0.41 | 0.43 | |
| 2023-12-31 | 0.55 | $0.96 | 0.58 |
| 2023-09-30 | 0.60 | $1.01 | 0.59 |
| 2023-06-30 | 0.95 | $1.03 | 0.92 |
| 2023-03-31 | 1.06 | $1.06 | 1.00 |
| 2022-12-31 | 0.79 | $1.04 | 0.76 |
| 2022-09-30 | 0.87 | $1.00 | 0.87 |
| 2022-06-30 | 0.96 | $0.96 | 1.00 |
| 2022-03-31 | 1.47 | $0.91 | 1.62 |
| 2021-12-31 | 1.47 | $0.88 | 1.67 |
| 2021-09-30 | 1.84 | $0.81 | 2.26 |
| 2021-06-30 | 1.56 | $0.75 | 2.07 |
| 2021-03-31 | 1.67 | $0.66 | 2.54 |
| 2020-12-31 | 1.50 | $0.69 | 2.18 |
| 2020-09-30 | 1.35 | $0.77 | 1.76 |
| 2020-06-30 | 1.15 | $0.83 | 1.39 |
| 2020-03-31 | 0.95 | $0.95 | 0.99 |
| 2019-12-31 | 2.08 | $1.00 | 2.09 |
| 2019-09-30 | 2.15 | $1.13 | 1.91 |
| 2019-06-30 | 2.49 | $1.16 | 2.15 |
| 2019-03-31 | 2.85 | $1.45 | 1.97 |
| 2018-12-31 | 2.60 | $2.75 | 0.95 |
| 2018-09-30 | 3.54 | $5.62 | 0.63 |
| 2018-06-30 | 2.05 | $8.30 | 0.25 |
| 2018-03-31 | 1.17 | $11.41 | 0.10 |
| 2017-12-31 | 1.23 | $13.12 | 0.09 |
| 2017-09-30 | 1.77 | $13.11 | 0.13 |
| 2017-06-30 | 2.43 | $13.81 | 0.18 |
| 2017-03-31 | 3.03 | $13.52 | 0.22 |
| 2016-12-31 | 2.20 | $13.12 | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.014B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |